Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity. [electronic resource]
Producer: 20080915Description: 698-700 p. digitalISSN:- 1755-3768
- Adult
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Female
- Glaucoma, Neovascular -- drug therapy
- Humans
- Infant, Newborn
- Injections
- Intraocular Pressure
- Iris -- blood supply
- Neovascularization, Pathologic -- drug therapy
- Retinal Detachment -- etiology
- Retinopathy of Prematurity -- complications
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
- Vitreous Body
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.